Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Quantification of neuroinflammation in spinal cord and neuroforamina of patients with painful cervical radiculopathy using [<sup>11</sup>C]DPA713 PET/CT.

Frontiers in nuclear medicine·2025

Same author

Impact of Ultrahigh Sensitivity and Continuous Bed Motion on Performance Characteristics of Biograph Vision Quadra PET/CT.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025

Same author

The Importance of PET Quantification for Prognosis and Treatment Response Monitoring.

PET clinics·2025

Same author

Can we obtain prognostic information from healthy tissue uptake and volume in baseline <sup>18</sup>F-FDG PET/CT imaging in diffuse large B-cell lymphoma?

European journal of nuclear medicine and molecular imaging·2025

Same author

Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease.

Brain : a journal of neurology·2025

Same author

Imaging Proinflammatory Microglia in Parkinson Disease Using [<sup>11</sup>C]SMW139 PET: A Multicenter Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat

A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat

Published on: December 28, 2013

Methodological aspects of multicenter studies with quantitative PET.

Ronald Boellaard¹

¹Department of Nuclear Medicine & PET Research, VU University Medical Centre, Amsterdam, The Netherlands. r.boellaard@vumc.nl

Methods in Molecular Biology (Clifton, N.J.)

|February 19, 2011

Summary

Variability in whole-body FDG PET quantification methods hinders data comparison. Standardizing techniques is crucial for reliable multicenter clinical trials using FDG PET imaging.

More Related Videos

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice

Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice

Published on: October 25, 2024

Related Experiment Videos

Last Updated: Jun 4, 2026

A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat

A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat

Published on: December 28, 2013

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice

Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice

Published on: October 25, 2024

Area of Science:

Nuclear Medicine
Medical Imaging
Radiochemistry

Background:

Whole-body FDG PET quantification is influenced by numerous physiological and physical factors.
Inconsistent methodologies across studies lead to significant variability in reported standardized uptake value (SUV) data.
This methodological variability impedes direct comparison and data exchange of quantitative FDG PET results.

Purpose of the Study:

To identify the primary causes of variability in whole-body FDG PET quantification.
To propose strategies for minimizing inter-institute variability in FDG PET imaging.
To facilitate the reliable use of quantitative PET data in multicenter clinical trials.

Main Methods:

Review of factors affecting FDG PET quantification, including scanner differences, acquisition/reconstruction settings, ROI selection, and normalization/correction methods.
Analysis of methodological variations reported in the literature.
Discussion of strategies to standardize FDG PET quantification protocols.

Main Results:

Significant inter-study variability exists due to diverse methodologies in FDG PET quantification.
Current inconsistencies prevent direct clinical application of findings from monocentric studies to multicenter trials.
Standardization is essential for leveraging the full potential of quantitative PET.

Conclusions:

Methodological heterogeneity is the main driver of variability in whole-body FDG PET quantification.
Implementing standardized protocols is imperative for reproducible and comparable quantitative PET data.
Standardization will enable the reliable translation of quantitative FDG PET findings into multicenter clinical practice.